Hallandale semaglutide was a popular compounded GLP-1 during the shortage. Learn what it was, its cost, FDA status, and whether it is still available.
Hallandale semaglutide refers to compounded semaglutide made by Hallandale Pharmacy, a 503A compounding pharmacy in Hallandale Beach, Florida. It became one of the most widely used compounded GLP-1 products in the United States during the semaglutide shortage, offering a lower-cost alternative to Ozempic and Wegovy. Federal regulators declared that shortage over on February 21, 2025, and 503A pharmacies were required to stop compounding semaglutide by April 22, 2025.
What "Hallandale Semaglutide" Actually Means
Semaglutide is the active drug in three FDA-approved brand-name medicines:
- Ozempic — a weekly injection approved for type 2 diabetes.
- Wegovy — a weekly injection approved for chronic weight management.
- Rybelsus — an oral tablet approved for type 2 diabetes.
Hallandale Pharmacy is a state-licensed 503A compounding pharmacy that mixed its own semaglutide formulations from bulk active pharmaceutical ingredient. Patients received a multi-dose vial and insulin syringes instead of the single-dose pen sold by Novo Nordisk.
Dosing was usually written in "units" on a U-100 syringe rather than in milligrams. That difference matters: anyone switching between a compounded vial and a brand-name pen has to have the dose recalculated by a prescriber to avoid an error.
Why Compounded Semaglutide Grew So Fast
Three forces pushed patients toward compounded versions between 2022 and 2025:
- Shortage. Demand for GLP-1 drugs outpaced manufacturing capacity, and many patients could not fill brand-name prescriptions consistently.
- Cost. Wegovy lists at about $1,349 per month and Ozempic at about $997 per month without insurance. Compounded vials typically cost $150 to $400 per month.
- Telehealth access. Online clinics prescribed and shipped compounded semaglutide without an in-person visit.
During a declared shortage, FDA guidance allowed compounders to produce copies of a commercially available drug. That exception disappeared once the shortage was resolved.
Is Hallandale Semaglutide Still Available?
No. Hallandale Pharmacy operates as a 503A pharmacy, and the FDA required 503A pharmacies to stop compounding semaglutide by April 22, 2025. Larger 503B outsourcing facilities had until May 22, 2025.
| Product | FDA approval | Compounding deadline |
|---|---|---|
| Ozempic, Wegovy, Rybelsus | FDA-approved | Not applicable |
| Compounded semaglutide from 503A pharmacies (including Hallandale) | Not FDA-approved | April 22, 2025 |
| Compounded semaglutide from 503B outsourcing facilities | Not FDA-approved | May 22, 2025 |
A compounding trade group sued the FDA over those deadlines, but courts allowed them to stand. Some websites still advertise compounded semaglutide, so patients should confirm which pharmacy is actually dispensing the drug and whether that pharmacy is still legally allowed to compound it.
Compounded drugs are not FDA-approved, and they are not reviewed by the FDA for safety, effectiveness, or quality before they are marketed.
Hallandale Semaglutide vs. Brand-Name Semaglutide
| Feature | Hallandale compounded semaglutide | Wegovy / Ozempic (Novo Nordisk) |
|---|---|---|
| FDA approval | None | Approved for specific indications |
| Typical monthly cost | $150–$400 | About $997–$1,349 before insurance |
| Dosing format | Vial plus syringe, dose in units | Single-dose pen, dose in milligrams |
| Oversight | State board of pharmacy and USP standards | FDA manufacturing and labeling rules |
| Availability in 2025 | Ended for 503A pharmacies on April 22, 2025 | Commercially available |
Formulation is another gap. Because compounded products do not have to match the brand's inactive ingredients, the semaglutide ingredients in a compounded vial can differ from those in Wegovy or Ozempic. Many compounded versions added vitamin B12, which changes the color of the liquid but not the active drug.
Safety, Side Effects, and Open Questions
The most common adverse effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal pain. Most occur during dose escalation and ease over time, but some patients stop treatment because of them.
Rare but serious risks include pancreatitis, gallbladder disease, gastroparesis, and acute kidney injury caused by dehydration. People with a history of those conditions should talk with a clinician before starting any GLP-1 drug.
The most-discussed long-term question involves cancer risk. Semaglutide carries a boxed warning about thyroid C-cell tumors observed in rodents, which is why searches for semaglutide side effects often return alarming headlines. The FDA states that it is unknown whether semaglutide causes these tumors in humans, and the drug should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN2.
Compounded products carry additional uncertainty. Because they are not FDA-reviewed, dosing errors, contamination, and potency variation are real concerns rather than theoretical ones.
Alternatives and What to Ask a Clinician
If compounded semaglutide is no longer an option for you, the realistic paths are:
- Brand-name semaglutide through insurance, a manufacturer savings card, or a cash-pay program.
- Tirzepatide (Zepbound, Mounjaro), a dual GIP/GLP-1 agonist that produced greater average weight loss than semaglutide in head-to-head trials.
- Clinical trials for investigational combinations. Researchers studying cagrilintide and semaglutide, for example, are testing a fixed-dose combination known as CagriSema in late-stage trials for obesity and type 2 diabetes.
Investigational drugs are not available by prescription, and no dosing regimen for the CagriSema combination has been approved by the FDA. The same caution applies to research peptides. Some people search for aod 9604 and semaglutide as a stacked approach, but AOD-9604 is an unapproved research peptide with no established human efficacy or safety data for weight loss.
Patient forums can be useful for practical tips but poor sources of medical guidance. Semaglutide pills reviews reddit threads, for instance, often mix oral Rybelsus, compounded drops, and injectables in a single conversation even though those products are not interchangeable.
Before you start or continue any GLP-1 medication, verify four things with a licensed clinician or pharmacist:
- Is the pharmacy licensed in your state and in good standing?
- Does the product come with a certificate of analysis?
- Is the dose documented in milligrams as well as units?
- Is there a plan for monitoring side effects and adjusting the dose?
The bottom line: Hallandale semaglutide was a legal, lower-cost compounded option during the GLP-1 shortage, but no compounded semaglutide is FDA-approved, and 503A pharmacies like Hallandale were required to stop making it by April 22, 2025. Patients who want semaglutide today should work with a prescriber to find an FDA-approved product, and they should treat any website still selling compounded semaglutide with caution.
Frequently Asked Questions
Is Hallandale semaglutide still available?
No. Hallandale Pharmacy is a 503A compounding pharmacy, and the FDA required 503A pharmacies to stop compounding semaglutide by April 22, 2025. Some telehealth sites still advertise compounded semaglutide, so it is worth confirming which pharmacy is actually shipping the product and whether that pharmacy is still permitted to compound it.
Is compounded semaglutide from Hallandale FDA-approved?
No. Compounded semaglutide is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality before they are sold. The active ingredient is the same molecule used in Ozempic and Wegovy, but the finished compounded product is not the same FDA-approved drug.
How much did Hallandale semaglutide cost?
Compounded semaglutide from telehealth programs generally cost about $150 to $400 per month, depending on the dose and the provider. That was far less than the list price of Wegovy (about $1,349 per month) or Ozempic (about $997 per month) without insurance, though prices and availability changed often during the shortage.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.